Learn about how it works, when doctors administer it, and more. Tenecteplase is an enzyme that, when present in blood in pharmacologic concentrations, remains active under in vitro conditions This can lead to degradation of fibrinogen in blood samples removed for analysis Inform patients that bleeding can occur 1 or more days after administration of tnkase. Tnk (tenecteplase) dissolves blood clots in certain blood vessels in your body Blood clots happen when your blood thickens.
The drug is in the tissue plasminogen activator (tpa) class of medications. Tenecteplase is used in adults to treat a stroke caused by a clot (acute ischemic stroke) and to lower the risk of death from a certain type of heart attack Tenecteplase may also be used for purposes not listed in this medication guide. Tenecteplase is an effective thrombolytic agent for eligible patients with stroke who are treated within 4.5 hours after the onset of stroke However, data regarding the effectiveness of. The original trial evaluated the noninferiority of tnk compared to tpa in chinese patients with acute ischemic stroke (ais).
It enhances the conversion of plasminogen to plasmin by binding to fibrin initiating fibrinolysis with limited systemic proteolysis.
WATCH
